首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Synthetic studies of the 18-membered antitumor macrolide, tedanolide. 3. Stereocontrolled synthesis of the C1-C12 part via a synthesis of the C1-C7 fragment by a mismatched but efficient sharpless dihydroxylation and its coupling with the C8-C11 frag
【24h】

Synthetic studies of the 18-membered antitumor macrolide, tedanolide. 3. Stereocontrolled synthesis of the C1-C12 part via a synthesis of the C1-C7 fragment by a mismatched but efficient sharpless dihydroxylation and its coupling with the C8-C11 frag

机译:18元抗肿瘤大环内酯泰达内酯的合成研究。 3.通过不匹配但有效的无尖锐二羟基化合成C1-C7片段及其与C8-C11碎片的立体控制的C1-C12片段的合成

获取原文
获取原文并翻译 | 示例
           

摘要

The C1-C12 part (4) of tedanolide (1) was synthesized starting from methyl (R)-3-hydroxy-2-methylpropionate (11a) via a coupling between the C1-C7 aldehyde (6) and the C8-C11 iodoalkene (7a). For a synthesis of 6, a mismatched but highly efficient Sharpless dihydroxylation of the alpha, beta-unsaturated ester (15) with AD-mix-alpha was successfully applied. Compound 7a was synthesized using hydrozirconation to the alkyne (32).
机译:从(R)-3-羟基-2-甲基丙酸甲酯(11a)经由C1-C7醛(6)与C8-C11碘代烯烃之间的偶合反应合成了tedanolide(1)的C1-C12部分(4) (7a)。对于6的合成,成功地应用了AD-mix-alpha错配但高效的Sharpless二羟基化的α,β-不饱和酯(15)。使用氢化锆合成炔烃(32)来合成化合物7a。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号